EUCTR2016-004763-40-FI进行中（未招募）1 期
Immunogenicity and Safety of Quadrivalent Influenza Vaccine (VaxigripTetra™) in Pregnant Women
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 729
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •- Aged at least 18 years on the day of inclusion
- •- Pregnant women with estimated gestational age of 20 to 32 weeks
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 729
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- Previous vaccination against influenza with the 2017-2018 Northern hemisphere formulation with either the trial vaccines or another vaccine
- •- Pregnancy complications (in the current pregnancy)
- •- Chronic illness that, in the opinion of the Investigator, is at a stage where it might interfere with trial conduct or completion
研究者
相似试验
进行中（未招募）
不适用
Safety and Immunogenicity of the Quadrivalent Influenza Vaccine Administered via the Intramuscular Route in Children Aged 3 to 8 YearsProphylaxis of influenza in children aged 3 to 8 yearsMedDRA version: 14.1Level: LLTClassification code 10022001Term: Influenza (epidemic)System Organ Class: 100000004862EUCTR2011-005374-33-FISanofi Pasteur1,225
进行中（未招募）
不适用
Safety and Immunogenicity of a Quadrivalent Influenza Vaccine Administered via the Intramuscular Route in Adult and Elderly SubjectsProphylaxis of influenza in subjects from 18 years of ageMedDRA version: 14.0Level: LLTClassification code 10022001Term: Influenza (epidemic)System Organ Class: 10021881 - Infections and infestationsEUCTR2011-001976-21-DESanofi Pasteur1,568
进行中（未招募）
不适用
Safety and Immunogenicity of a Quadrivalent Influenza Vaccine inChild/Adolescent and Adult SubjectsProphylaxis of influenza in subjects from 9-17 years of age (and adults aged 18 to 60 years).MedDRA version: 14.1Level: LLTClassification code 10022001Term: Influenza (epidemic)System Organ Class: 10021881 - Infections and infestationsEUCTR2011-005101-79-Outside-EU/EEASanofi Pasteur2,083
进行中（未招募）
不适用
Immunogenicity and Safety of the Trivalent Influenza Vaccine (Split-Virion, Inactivated), Northern Hemisphere 2013-2014 Formulation (Intradermal Route)Prophylaxis of influenza (2013-2014 Northern Hemisphere Season)MedDRA version: 16.1Level: LLTClassification code 10022001Term: Influenza (epidemic)System Organ Class: 100000004862EUCTR2012-005243-25-FRSanofi Pasteur
已完成
3 期
Study of the Quadrivalent Influenza Vaccine in Participants 6 Months of Age and Older in IndiaCTRI/2021/11/037841Sanofi Healthcare India Private Limited SHIP400